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Abstract
Determining the structure of the (oligomeric) intermediates that form during the
self-assembly of amyloidogenic peptides is challenging because of their heteroge-
neous and dynamic nature. Thus, there is need for methodology to analyze the
underlying molecular structure of these transient species. In this work, a combination
of fluorescence quenching, photo-induced crosslinking (PIC) and molecular dynamics
simulation was used to study the assembly of a synthetic amyloid-forming peptide,
Aβ16-22. A PIC amino acid containing a trifluormethyldiazirine (TFMD) group—Fmoc
(TFMD)Phe—was incorporated into the sequence (Aβ*16–22). Electrospray ionization
ion-mobility spectrometry mass-spectrometry (ESI-IMS-MS) analysis of the PIC prod-
ucts confirmed that Aβ*16–22 forms assemblies with the monomers arranged as anti-
parallel, in-register β-strands at all time points during the aggregation assay. The
assembly process was also monitored separately using fluorescence quenching to
profile the fibril assembly reaction. The molecular picture resulting from discontinu-
ous molecule dynamics simulations showed that Aβ16-22 assembles through a single-
step nucleation into a β-sheet fibril in agreement with these experimental observa-
tions. This study provides detailed structural insights into the Aβ16-22 self-assembly
processes, paving the way to explore the self-assembly mechanism of larger, more
complex peptides, including those whose aggregation is responsible for human
disease.
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1 | INTRODUCTION
Self-assembling peptides can be difficult to study in vitro because of
their hydrophobicity and propensity to aggregate into high orderSamuel J. Bunce and Yiming Wang authors contributed equally to this work.
Received: 15 July 2020 Revised: 7 October 2020
DOI: 10.1002/aic.17101
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2020 The Authors. AIChE Journal published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
AIChE J. 2020;e17101. wileyonlinelibrary.com/journal/aic 1 of 12
https://doi.org/10.1002/aic.17101
assemblies.1-4 Consequently, shorter synthetic peptide fragments from
longer amyloidogenic sequences offer convenient model systems with
which to explore peptide self-assembly.5,6 A case in point is the
Gly-Asn-Asn-Gln-Gln-Asn-Tyr (GNNQQNY) sequence, taken from the
prion-determining domain (PrD) of the 635 residue Sup35 yeast pro-
tein.7,8 Eisenberg and co-workers established in 2001 that in aqueous
conditions this sequence self-assembles into highly ordered fibril struc-
tures that display the characteristic cross-β X-ray diffraction pattern of
amyloid.6 The short nature of GNNQQNY enabled the formation of
micro-crystals suitable for electron diffraction, which demonstrated
that in the crystals the peptide had formed a parallel in-register β-sheet
structure involving a steric zipper with a dry interface between the
interdigitated side-chains.7 GNNQQNY clearly demonstrates that pep-
tide fragments can be useful models of longer amyloid sequences,
revealing atomic level information about short segments that may be
relevant to the assembly of their longer peptide counterparts.
One of the most widely studied short amyloidogenic sequences is
Aβ16-22 (Ac-Lys-Leu-Val-Phe-Phe-Ala-Glu-CONH2), a seven-residue
peptide that comes from the central fibril-forming region of the Aβ
sequence associated with Alzheimer's disease.5 Aβ16-22 is one of the
smallest Aβ fragments that forms fibrils with a cross-β structure and
can be readily synthesized using solid phase peptide synthesis (SPPS).
Substitutions within this region of full-length Aβ peptide have been
shown to affect its aggregation propensity in vitro and in vivo,
highlighting the importance of the motif.9-11 These findings make
Aβ16-22 a convenient model with which to explore the underlying
steps in an aggregation mechanism. The noted ability of Aβ16-22 to
form a range of supramolecular structures at different pH values fur-
ther highlights the value of using Aβ16-22 to understand the funda-
mental molecular mechanisms of peptide self-assembly and the
molecular origins of fibril polymorphism.12,13 Tycko and co-workers
used solid-state NMR, transmission electron microscopy (TEM) and X-
ray diffraction to establish that at neutral pH Aβ16-22 formed in-regis-
ter, anti-parallel fibril structures that displayed green birefringence
when bound to Congo-Red.5 In X-ray diffraction experiments the
fibrils displayed periodic reflections at 4.9 and 9.9 Å, characteristic of
the spacing between β-strands and β-sheet layers, respectively.14,15
A key goal in studying Aβ16-22 is to understand the transitions
that occur during self-assembly. Petty and Decatur used isotope-
edited IR to establish that at neutral pH, Aβ16-22 assembles with
monomers adopting an initial β-strand alignment that is not identical
to the final equilibrium alignment, that is, there is some β-sheet reor-
ganization during the self-assembly process.16 Lynn and co-workers
demonstrated that at both acidic and neutral pH, Aβ16-22 passes
through an intermediary out-of-register ribbon-like structure.13 The
time taken to reach the final fibril alignment (measured by CD) was
different at each pH: at neutral pH Aβ16-22 reached a plateau after
5 days, whereas at acidic pH a lag phase of 4 days was observed, with
the final plateau being reached after 10 days.13 Aβ16-22 has also been
shown to form micrometer sized particles with a high concentration
of peptides in a liquid-like state.17,18 These particles are metastable
(containing around 20–33% β-sheet content) and can undergo a phase
transition to form nanotubes or fibrils at certain temperatures and pH
values. In all cases, it should be noted that changes in temperature,
peptide concentration and ionic strength can have a significant impact
on the kinetics of Aβ16-22 aggregation, confounding comparison
between different studies.12,13,18,19
Since the transient intermediates that form during the early stages
of peptide self-assembly can be difficult to characterize experimentally,
molecular dynamics (MD) simulations can provide useful insights.20-22
The first studies, carried out by Klimov and Thirumalai, demonstrated
that monomeric Aβ16-22 preferentially adopts either a random coil or
extended β-sheet conformation.20 These structures then progress
through an obligatory α-helical intermediate prior to forming stable anti-
parallel, in-register oligomers. Later studies also observed that Aβ16-22
monomers adopt primarily random coil conformations, although the
presence of an α-helical intermediate was disputed.21,22 These simula-
tions also highlighted the complex pathways that Aβ16-22 accesses during
the self-assembly process and that the anti-parallel, in-register structure
is the preferred structure due to its stability. Hall and co-workers23
applied discontinuous molecular dynamics (DMD) and a coarse-grained
protein model (PRIME20) to demonstrate that at high simulation temper-
atures, a system of 48 monomeric Aβ16-22 peptides aggregates via classi-
cal nucleation and growth into a highly-ordered structure with
monomers organized as anti-parallel, in-register β-strands in agreement
with the solid-state NMR measurements reported by Tycko and co-
workers.5 At lower simulation temperatures, Aβ16-22 first forms β-sheet-
rich oligomers which then merge and rearrange into a large fibril. Later,
Hall and co-workers24 combined the DMD/PRIME20 simulation with
classical nucleation theory to construct a thermodynamic (solubility)
phase diagram for Aβ16-22, which agrees well with in vitro solubility mea-
surements. Recently, PRIME20/DMD simulations were combined with
electrospray ionization ion-mobility spectrometry mass-spectrometry
(ESI-IMS-MS) measurements to reveal structural insights on the second-
ary nucleation mechanism of Aβ1-40 peptide on Aβ16-22 fibril surface.25
In this work, we combine experimental and molecular simulation to
understand and characterize, at the molecular level, the transitions that
Aβ16-22 undergoes as it self-assembles. We used photo-induced
crosslinking (PIC) combined with ESI-IMS-MS to derive insights on the
noncovalent organization of Aβ16-22 during different phases of its self-
assembly reaction. The simulation results are in close agreement with
experimental results, and indicate that the dominant pathway by which
Aβ16-22 assembles involves monomers organized as anti-parallel, in-
register β-strands at all time points. The results highlight the power of
combining PIC with ESI-IMS-MS/MS, fluorescence quenching and
DMD simulations to study kinetic intermediates in peptide self-assem-
bly, and paves the way for exploring the self-assembly of larger, more
complex peptides, including those directly relevant to amyloid disease.
2 | MATERIALS AND METHODS
2.1 | Solid Phase Peptide Synthesis of Aβ16-22
All amino acids, 4-(trifluormethyldiazirine)phenylalanine (TFMD-Phe),
Aβ16-22 (Ac-Lys-Leu-Val-Phe-Phe-Ala-Glu-NH2), Aβ16–22 N-terminally
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labeled with tetramethylrhodamine (TAMRA) including a
6-aminohexanoic acid linker (Ahx); TAMRA-Ahx-Aβ16-22 and Aβ16-22
functionalized TFMD-Phe; Aβ*16–22 (Ac-Lys-Leu-Val-Phe-(TFMD)Phe-
Ala-Glu-NH2) were prepared as described previously.
25-27
2.2 | Fluorescence quenching assays
Fluorescence quenching assays were carried out as described previ-
ously.25 Briefly Aβ16–22 was spiked with 5% (w/w) TAMRA-Ahx-
Aβ16–22 (total peptide concentration, 20 or 40 μM) in 100 mM ammo-
nium bicarbonate buffer (pH 7.4) with a final concentration of 2%
(v/v) DMSO. Samples were placed in quartz cuvettes and analyzed
using a temperature-controlled fluorimeter at 37C. Time points were
taken every 30 s for the duration of the experiment. The TAMRA fluo-
rophore was excited at 520 nm, and emission was recorded at
600 nm to reduce the inner filter effect.
2.3 | TEM analyses
Samples were prepared and analyzed by TEM as described
previously.25 Briefly, TEM images were taken at the stated time points
and at the end of each experiment by removing 5 μl from the assem-
bly reaction and incubating this sample on carbon–formvar grids for
30 s before staining with 2% (w/v) uranyl acetate solution for an addi-
tional 30 s. Images were taken on a JEM-1400 (JEOL Ltd., Tokyo,
Japan) or a Tecnai F12 TEM. (FEI, Hillsboro, OR) TEM. Images were
taken using either an ATM charge-coupled device (CCD) camera or a
Gatan UltraScan 1,000 XP (994) CCD camera (JEM-1400) or an Ultra-
Scan 100XP (994) CCD camera (Tecnai F12). Once taken, images
were processed using ImageJ (National Institutes of Health [NIH]).
2.4 | Photo-induced cross-linking
Aβ*16–22 (40 μM total peptide concentration) in 100 mM ammonium
bicarbonate buffer (pH 7.4) with a final concentration of 1% (v/v) DMSO
was incubated quiescently in Eppendorf tubes for 0 min, 5 min, or
24 hr. Samples were then irradiated for 30 s using a light-emitting diode
lamp at 365 nm,28 then removed, lyophilized overnight, redissolved in
hexafluorisopropanol (HFIP) for at least 2 hr, and vortexed to ensure dis-
aggregation. HFIP was then removed under a stream of N2, and the
sample was re-suspended in 50:50 (v/v) MeCN/H2O containing 0.05%
(v/v) formic acid to a final peptide concentration of 40 μM. Cross-links
were then analyzed using ESI-IMS-MS/MS as described below.
2.5 | Electrospray ionization ion-mobility
spectrometry mass-spectrometry (ESI-IMS-MS/MS)
All samples were prepared as described above and left to incu-
bate at 37C without agitation for 5 min. A SYNAPT HDMS
quadrupole time-of-flight MS (Micromass UK Ltd., Waters Corp.,
Manchester, UK), equipped with a TriVersa NanoMate (Advion
Biosciences, Ithaca, NY) automated nano-ESI interface was used
in this study. The instrument has a traveling-wave IMS device sit-
uated in between the quadrupole and the time-of-flight analyzer.
Samples were analyzed by positive ionization nano-ESI, with a
capillary voltage of 1.4 kV and a nitrogen-nebulizing gas pressure
of 0.8 psi. The following instrumental parameters were set: cone
voltage, 60 V; source temperature, 60C; backing pressure,
4.7 mbar; ramped traveling speed, 7 to 20 V; traveling wave
speed, 400 m s−1; IMS nitrogen gas flow, 20 ml min−1; IMS cell
pressure, 0.55 mbar. The mass/charge ratio (m/z) scale was cali-
brated using aq. CsI cluster ions. Collision Cross Section (CCS)
measurements were estimated using a calibration obtained by
analysis of denatured proteins (cytochrome c, ubiquitin, and alco-
hol dehydrogenase) and peptides (tryptic digests of alcohol dehy-
drogenase and cytochrome c), with known CCSs obtained
elsewhere from drift tube ion mobility measurements.29,30 The
CCS (Ω) of the peptide monomers/oligomers was then calculated
according to Equation (1):
Ω ˚A2
 









where A is the determined calibration constant, z is the charge state
of the ion, B is the exponential factor (determined experimentally), tD
is the corrected absolute drift time, mion is the mass of the ion and
mgas is the mass of the gas used in the ion-mobility cell (N2). Data
were processed using MassLynx v4.1 and Driftscope software sup-
plied with a mass spectrometer.
2.6 | DMD simulation
In this work, three independent DMD/PRIME20 simulations were
carried out for 12 μs in the canonical (NVT) ensemble. The two
major nonbonded interactions of the PRIME20 model are the
directional square-well backbone hydrogen bonding interaction and
the nondirectional square-well potential interaction between two
sidechain beads. The potential energy parameters between the
20 different amino acids include 210 independent square-well
widths and 19 independent square-well depths derived by using a
perceptron learning algorithm that optimizes the energy gap
between 711 known native states from the Protein Data Bank
and decoy structures.31 The Andersen thermostat was
implemented to maintain the simulation system at a constant tem-
perature.32 One hundred and ninety-two peptides were initially
randomly placed in a cubic box with a length of 321.0 Å,
corresponding to a peptide concentration of 10 mM. The reduced
temperature is defined to be T* = kBT/εHB, where εHB = 12.47 kJ/
mol is the hydrogen bonding energy. The reduced temperature T*
of the simulations was set to be 0.193, which corresponds to
326 K in real temperature units.33
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3 | RESULTS AND DISCUSSIONS
3.1 | Time course of Aβ16-22 aggregation
To monitor the time course for Aβ16-22 aggregation, we used a fluo-
rescence quenching assay (Figure 1) in which sub-stoichiometric addi-
tion of a fluorescently labeled peptide, Aβ16–22 N-terminally labeled
with tetramethylrhodamine (TAMRA) including a 6-aminohexanoic
acid linker (Ahx); TAMRA-Ahx-Aβ16-22, was included in the Aβ16-22
assembly reaction (Aβ16–22/5% (w/w) TAMRA-Ahx-Aβ16–22 total pep-
tide concentration, 20 or 40 μM). This assay, which is first used to
study the aggregation of Aβ40 and Aβ42,34 operates on the principle
that fluorophores in adjacent peptides in an aggregated state are
proximal and therefore self-quench. We used this assay in our
previous study on secondary nucleation of Aβ40 by Aβ16-22.25 Here,
two different concentrations of Aβ16-22 were tested (20 and 40 μM);
both self-assembly reactions (Figure 1a,b) proceed with a rapid initial
decrease in fluorescence intensity followed by a second, slower,
phase that reaches a plateau after around 1 hr.
Although a powerful method with which to measure the kinetics
of peptide self-association in amyloid formation, fluorescence
quenching is limited in that it reports only on the proximity of the
fluorophores, but does not provide any information about the under-
lying structure(s) formed. To further understand the aggregation pro-
cess of Aβ16-22, samples were taken during the aggregation time
course after 5 min, 1 hr, and 24 hr, and analyzed by TEM (Figure 1c).
At 5 min fibrils were observed with a small amount of amorphous
aggregates also present. After a 1 hr incubation at 37C, no
F IGURE 1 Schematic of the fluorescence quenching assay used in this work. As TAMRA-Ahx-Aβ16-22 is incorporated into the fibrils the
fluorophores come into close contact and fluorescence is quenched. The aggregation kinetics of Aβ16-22 is monitored using fluorescence
quenching. At both 40 and 20 μM (a and b, respectively), Aβ16-22 displays two-phase aggregation kinetics with the quenching reaching a plateau
after around 1 h (100 mM ammonium bicarbonate buffer pH 7.4 with a final concentration of 2% (v/v) DMSO). In a TEM time course (c), Aβ16-22
(40 μM) forms highly ordered fibril structures within 5 min. Scale bar = 200 nm [Color figure can be viewed at wileyonlinelibrary.com]
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amorphous aggregates could be seen and increased numbers of fibrils
were observed on the grids. At these early time points, the fibrils were
well dispersed without significant bundling, whereas at later time
points (e.g., after 24 hr) significant bundling of the Aβ16-22 fibrils was
observed. The results show that under the conditions employed in this
study, Aβ16-22 forms fibril structures rapidly (within 5 min), with
increased numbers of fibrils formed at later times bundling together
as the self-assembly reaction proceeds.
3.2 | Using ESI-IMS-MS and PIC to monitor
structures formed during Aβ16-22 aggregation
After establishing the aggregation kinetics of Aβ16-22, the next step
was to probe the structure(s) that Aβ16-22 accesses during its transi-
tion from a monomer to a highly ordered β-sheet lattice within
amyloid-like fibrils. This was achieved using Aβ16-22 functionalized
with 4-(trifluormethyldiazirine)phenylalanine (TFMD)Phe (named
herein as Aβ*16–22). The requisite amino acid (TFMD-Phe) and peptide
labeled with (TFMD)Phe at position 20 (Aβ*16–22, Figure 2) were pre-
pared as described previously (Section 2).25,26 Importantly, we have
shown previously that the incorporation of (TFMD)Phe at positions
19 and 20 in Aβ16-22 does not impede aggregation of the peptide nor,
in the case of the F20 variant, does it alter the structure of the fibrils
formed.25,26 We reconfirmed these observations under the conditions
used in this work; showing that Aβ*16–22 aggregates to yield morpho-
logically similar fibrils to those observed for Aβ16-22 (Figure S1).
3.3 | Analysis of cross-linked products
Cross-linking studies focused on homomeric assembly reactions of
Aβ*16–22, that is, every peptide in the sample contained a TFMD group
at position Phe20. On photolysis, (TFMD)Phe produces a highly reac-
tive carbene which can insert rapidly and indiscriminately into proxi-
mal bonds to form a permanent covalent link.28,35 As we have shown
previously, such cross-linking approaches can yield information on
noncovalent organization in self-assembled structures.26,27 Fig-
ures S1b and c show the ion mobility spectrometry coupled to con-
ventional mass spectrometry (IMS-MS) analyses of the PIC
experiment performed on Aβ*16–22 after 2 weeks incubation at which
time (Figure S1C) fibrils are formed. The resulting mass spectrum
identified five major species as photolysis products (Figure S1c).
Importantly, the IMS function on the mass spectrometer can provide
additional information as it facilitates separation of ions with similar
m/z ratios; cross-linked monomer, dimer and small amounts of trimer
could be observed within the sample, in agreement with our previ-
ously published studies (Figure S1B).26,27
Tandem MS/MS sequencing fragments a peptide along its amide
backbone, producing a variety of different fragment ions.36-39 MS/MS
analyses of cross-linked peptides allow the site(s) of crosslinking to be
identified. While the peptide backbone experiences fragmentation,
inter- and intramolecular crosslinks do not, and so the covalent connec-
tivity between cross-linked peptide products is preserved and their
location can be established from the fragmentation pattern. Consistent
with our previous studies,26,27 the salient conclusions of this analysis
are that PIC of the Aβ*16–22 fibrils (Figure 3a) results in formation of
intramolecular cross-links between Phe20 and Glu22, together with
intermolecular cross-links between Phe20 and Lys16. These data are
consistent with an assembly whereby noncovalent interactions orga-
nize peptide monomers as in-register anti-parallel β-strands in Aβ16-22,
fibrils (according to definitions described by Eisenberg and Sawaya40),
in agreement with our earlier studies.26,27 In such an arrangement,
Phe20 is directly opposite Val18 on the adjacent strand with Lys16
diagonal to Phe20 (Figure 3b). However, rotation about the α-β bond
allows side chains to adopt a range of orientations, and can be easily
visualized in the structure of a related peptide Lys-Val-Leu-Phe-Phe-
Ala (PDB ID: 2AYA)41 whereby the corresponding Phe and Lys side-
chains are in mutual proximity and would be expected to cross-link
more easily. Such a relationship would not be possible for alternate
configurations (see Figure 3c for antiparallel in-register and Supporting
Information for further alternatives). Moreover subtle differences in
reactivity preference of the carbene arising from diazirine photolysis
could also lead to preferential reaction with Lys16 rather than Val18.
3.4 | Aβ16-22 forms anti-parallel, in-register
β-sheets in early protein assemblies
The mass spectrum of cross-linked products from Aβ*16–22 assembly
taken at different time points (5 min, 1 hr, 24 hr, and 2 weeks) is
shown in Figure 4. Intermolecular cross-links can be seen at all time
points, with the intensity (relative to the H2O quenched Aβ16-22)
increasing as time progresses. This could be attributed to an increase
in the amount of fibrils formed as the incubation time is increased, or
the bundling of the Aβ16-22 fibrils after aggregation is complete. Both
would increase the concentration of “dry interfaces” from which H2O
is excluded, allowing the carbene to react with peptide side-chains,
rather than being quenched with H2O to form a hydroxyl group.
35 At
each time point, both dominant intermolecular cross-link peaks
(i.e., m/z 998.58 and 983.50) were isolated and sequenced by
MS/MS. The results from sequencing the peak at m/z 988.58
(Figure 5) are consistent with those established from sequencing of
the disaggregated fibrils after 2 weeks, that is, they indicate the pres-
ence of β-sheet structure in which monomers are organized as inF IGURE 2 The molecular structure of Aβ*16–22
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register anti-parallel β-strands. The absence of any other cross-links
can be interpreted as follows: (a) Aβ16-22 assembly proceeds through
oligomers in which monomers are aligned as anti-parallel, in-register
β-strands akin to those in the fibrillar state or (b) cross-linking reports
only on oligomeric and fibrillar assemblies where monomers are
assembled as anti-parallel in register β-strands, with the remaining
species being either too heterogeneous to be sufficiently populated
for detection by mass-spectrometry or too disordered to generate
cross-links other than to water and buffer components.
3.5 | Large scale DMD simulations of Aβ16-22
assembly
To help determine the nature of oligomers formed during Aβ16-22
assembly, DMD and PRIME20 simulations were performed to
visualize the transitions that occur during the self-assembly process.
The simulations were conducted as described in Section 2 and a series
of simulation snapshots were taken at different time points, as shown
in Figure 6. After 652 ns of simulation time, most peptides were still
in a random coil conformation with some disordered aggregates and
small amounts of ordered oligomers present. As the simulation prog-
ressed (1,278 ns), the formation of an anti-parallel, in-register oligo-
mer could be clearly seen, as well as a small amount of disordered
aggregates. This is in excellent agreement with the structures
observed by TEM at early time points (5 min) where both fibrils and
amorphous aggregates are present. At later time points (2,519 and
6,283 ns), most peptides were in ordered aggregates with anti-parallel,
in-register structures dominating. A single, four-layered β-sheet struc-
ture was present at the simulation end point (12,661 ns). Again, these
results are in close agreement with the experimental data, in which
both ordered fibrils and amorphous aggregates were observed at early
F IGURE 3 Aβ*16–22 forms
antiparallel, in-register β-sheets after
2 weeks incubation time. (a) The fully
assigned tandem MS/MS spectrum for
the peak at m/z 988.58 (2+; mass
1975.16 Da) contains b ions (red,
e.g., at 1503.82 corresponding to the
loss of F*AE i.e., TFMD-Phe-Ala-Glu),
y ions (green, e.g., at 1692.95
corresponding to the lost of Lys-Leu)
and double fragmentation products
(blue). The two major fragmentation
series (b and y ion) located the cross-
link position to Lys16 and Phe20 on
the acceptor chain respectively. Both
of these cross-link patterns are
consistent with an antiparallel in-
register β-strand assembly. Cartoon
schematic (b) for in-register
antiparallel and (c) out-of-register
antiparallel organization of strands
(top shows side, bottom shows angle
from above, pink arrows illustrate
crosslinks observed in this or earlier
studies, salmon arrows show contacts
observed from MD simulations [see
later]). (d) Structure of Lys-Val-Leu-
Phe-Phe-Ala depicting in-register
antiparallel organization of strands
highlighting proximity of Phe and Lys
(pink arrows) between adjacent
strands (alternate strands shown in
cyan and top shows above, bottom
shows angle from above) [Color figure
can be viewed at
wileyonlinelibrary.com]
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time points (presumably after a hydrophobic collapse of the peptides
upon solvation), prior to the disappearance of the amorphous aggre-
gates and continued formation of fibrils.
The kinetics of Aβ16-22 aggregation can be measured in the simu-
lation by calculating the percentage of residues that are in a β-sheet
conformation at different simulation times. Figure 7 demonstrates
that, in agreement with the fluorescence quenching data, aggregation
proceeds via a rapid increase in β-sheet content, as measured by the
decrease in the system potential energy (from 0 to 50% in the first
4,000 ns) followed by a slower second phase (4,000–12,000 ns). The
TEM time course (Figure 1) and the simulation snapshots (Figure 6;
i.e., hydrophobic collapse and the presence of small amounts of fibrils
at early time points followed by a transition to/continued fibril forma-
tion) are concordant, as is the two phase kinetics observed in both the
fluorescence quenching and the simulations.
3.6 | Side-chain contacts formed during DMD
simulations of Aβ16-22 self-assembly
The DMD/PRIME20 simulations approach taken in this study can also
be used to assess the distance between the beads which represent
specific side-chains beads as the simulation progresses and may be
able to identify structures that cannot be resolved in the PIC experi-
ment. To do this, the nearest interpeptide sidechain contacts for all
Phe19 and Phe20 residues in the system are calculated and shown in
Figure 8. Figure S2 shows a schematic illustrating the simplest anti-
parallel/ parallel in-register/out-of-register potential arrangements
that can be envisioned. At the simulation end point, both Phe19 and
Phe20 make the most contacts with the residues that are directly
opposite their side-chains in an anti-parallel, in-register orientation
(Phe19 and Val18, respectively, see Figure 3). Although in isolation
the Phe19-Phe19 contact observed in the simulation would be consis-
tent with both parallel and anti-parallel orientations of monomers as
in-register β-strands, in combination with the Phe20 data, the identi-
fied contacts are most consistent with an anti-parallel, in-register ori-
entation as the dominant mode of interaction. The discrepancy
between these MD simulations and the PIC experiments where a
cross-link between Lys16 and Phe20 dominates is reconciled by the
fact that PRIME 20 models amino acid side chains as spheres, thus
such rotational preferences are not resolved and, instead, a simple dis-
tance relationship is observed. Within the data, three distinct phases
are observed, which occur on the 0–2,000, 2,000–4,000, and
4,000–12,000 ns timescales. As can be seen in Figure 8a, the second
most frequent contact that residue Phe19 makes during the simula-
tion is with Val18 (curve labeled Phe19-Val18). This contact increased
steadily until 2,000 ns, at which point no further increase occurred.
Contact between Phe19 and Val18 would be possible in a parallel
out-of-register conformation (Figure S2). When analyzing the contacts
that Phe20 forms during this initial period (Figure 8b), two significant
F IGURE 4 At all time points
analyzed Aβ*16–22 forms both
intra- and intermolecular peptide
cross-links. Products from the
reaction between the carbene
and H2O are labeled in blue and
peptide cross-links are labeled in
black [Color figure can be viewed
at wileyonlinelibrary.com]
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contacts (other than the dominant Phe20-Val18 contact) are
observed: Phe20-Leu17 and Phe20-Phe20. Phe20-Leu17 interac-
tion would not occur for any of the simplest monomer organiza-
tions; this contact again continued to increase in population until
2,000 ns at which time the number of contacts remained stable
for the rest of the simulation. The Phe20-Phe20 contact, possible
in a parallel-in-register alignment (Figure S2), increased at a slightly
slower rate than the Phe20-Leu17 contact in the first phase. How-
ever, rather than stopping at 2000 ns, it continued to increase until
it plateaued at 4,000 ns. Taken together, the results suggest that
as the simulation progresses, an anti-parallel in-register β-sheet
forms, while a plethora of alternative structures are also present
including disordered aggregates (particularly at early time points),
where a heterogeneous distribution of sidechain contacts would be
expected. After 2000 ns, however, the anti-parallel, in-register
alignment starts to dominate, while the contacts for other align-
ments plateau, indicating that these structures no longer grow, and
may interconvert to the in-register alignment, in agreement with
the experimental observations made by Lynn and co-workers.13
These series of simulations demonstrate the power of combining
F IGURE 5 Annotated
tandem MS/MS spectra
demonstrating that at all time
points analyzed Aβ*16–22 forms
anti-parallel, in-register β-strands.
In the spectra, b ions are
highlighted in red, y ions in green
and any double fragmentation
products in blue [Color figure can
be viewed at
wileyonlinelibrary.com]
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simulations and experimental data to gain a fuller picture of pep-
tide self-assembly at an atomistic level.
3.7 | Proposed mechanism of aggregation and
comparison with previously proposed Aβ16-22
aggregation mechanisms
According to the experimental data, the following mechanism for
Aβ16-22 self-assembly is proposed (Figure 9): peptides aggregate rap-
idly, forming both fibrils and small amounts of amorphous aggregates
(the initial decrease in fluorescence,  5 min). These amorphous
aggregates then form fibrils, with most of the self-assembly reaction
completed within 1–2 hr (as evidenced by the plateau in the fluores-
cence quenching data). The fibrils formed at these time points tend to
be isolated and unbundled. As the self-assembly reaction continues,
the fibrils start to bundle together and coalesce, forming dense mats
of fibril structures (after 2 weeks). These large mats (partly) exclude
H2O, forming a series of dry interfaces, in turn reducing the opportu-
nity for H2O to quench the carbene and promoting the formation of
interpeptide cross-links.
Lynn and co-workers previously observed a transition from out-
of-register, anti-parallel β-sheets before Aβ16-22 assembles into its
final in-register alignment.13 No such transition was discernable in our
cross-linking data. There could be a number of reasons for this:
1. The out-of-register alignment may be lowly populated compared
with the in-register alignment and as such may not be captured by
the cross-linking experiments at early time points; this is supported
by our simulations.
F IGURE 6 DMD simulation of 192 Aβ16-22 peptides at T* = 0.193
(T = 326 K). Snapshots of the system were taken at 0 ns (a), 652 ns
(b), 1,278 ns (c), 2,519 ns (d), 6,283 ns (e) and 12,661 ns (f)
F IGURE 7 (a) System potential
energy profile versus time and
(b) Percentage of residues that adopt
β-sheet structures in the system
versus time
F IGURE 8 Analysis of the closest interpeptide sidechain contacts
formed by F19 (a) and F20 (b) with the other residues of Aβ16-22 in
the system as a function of simulation time [Color figure can be
viewed at wileyonlinelibrary.com]
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2. The experimental conditions in this study and the previously
reported work of Lynn and co-workers were different. The prior
publication focused on self-assembly carried out in H2O and 40%
MeCN with no added salt (i.e., at very low ionic strength), and at
higher Aβ16-22 concentration (1.3 mM)42 whereas in the present
study self-assembly was carried out in 100 mM ammonium bicar-
bonate buffer with a peptide concentration of 40 μM. This could
cause the out-of-register alignment to be disfavored and there-
fore bypassed, or to be present only transiently prior to the time-
point at which useful cross-linking data could be obtained
(i.e., 5 min).
4 | CONCLUSION
In this work, Aβ16-22, a TAMRA-labeled Aβ16-22 peptide variant and an
Aβ*16–22 peptide variant were synthesized and used in fluorescence
quenching and PIC assays to demonstrate that Aβ16-22 aggregates in
two distinct phases. In the first phase, the peptides self-assemble into
β-sheet assemblies causing the fluorescence intensity to decrease rap-
idly (10 min). This is followed by a slower, second phase that pla-
teaus after 1–2 hr. A TEM time course confirmed that fibrils are
present after 5 min. To characterize the structures at a number of dif-
ferent time points, the PIC reagent Fmoc-TFMD-Phe was synthesized
and incorporated into Aβ*16–22. PIC with ESI-IMS-MS/MS at different
time points confirmed that Aβ*16–22 forms assemblies in which mono-
mers are organized as anti-parallel, in-register β-strands at all time
points. These experimental results were then compared with a series
of detailed DMD simulations that are in agreement with the experi-
mental data and allow a molecular mechanism to be proposed for
Aβ16-22 assembly under the conditions used in this study, where the
dominant pathways involve oligomers where monomers are organized
into anti-parallel, in-register β-strands. The DMD results also highlight
the presence of intermediary structures that could not be trapped by
PIC. Together, the results demonstrate that the combination of
crosslinking and MD represents a powerful toolkit with which to visu-
alize the mechanisms of peptide aggregation in molecular and kinetic
detail. Such approaches provide proof-of-concept for the application
of these methods to the study of: (i) disease relevant amyloidogenic
peptides (e.g., in Alzheimer's and Parkinson's disease) and (ii) peptide
materials.
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